Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 7
Submit an article Journal homepage
1,125
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The experience of patients with acute myeloid leukemia in remission post-transplant

David Cellaa Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0002-9881-4541View further author information
ORCID Icon,
Kimberly Kellyb IQVIA, New York, NY, USAView further author information
,
Anna de la Motteb IQVIA, New York, NY, USAView further author information
,
Farah Toublanb IQVIA, New York, NY, USAView further author information
,
Bhavik J. Pandyac Astellas Pharma Global Development Inc, Northbrook, IL, USACorrespondence[email protected]
View further author information
,
Manasee V. Shahc Astellas Pharma Global Development Inc, Northbrook, IL, USAView further author information
&
Thomas W. LeBlancd Department of Medicine, Duke University School of Medicine, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0002-0546-7895View further author information
ORCID Icon show all
Pages 1275-1284 | Received 22 Nov 2022, Accepted 19 Apr 2023, Published online: 08 Jun 2023

References

  • Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.
  • Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374(23):2209–2221.
  • Leukemia & Lymphoma Society. Facts and statistics overview. 2022. https://www.lls.org/facts-and-statistics/facts-and-statistics-overview
  • Thol F, Ganser A. Treatment of relapsed acute myeloid leukemia. Curr Treat Options Oncol. 2020;21(8):66.
  • Yilmaz M, Wang F, Loghavi S, et al. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia? Blood Cancer J. 2019;9(2):7.
  • Kassim AA, Savani BN. Hematopoietic stem cell transplantation for acute myeloid leukemia: a review. Hematol Oncol Stem Cell Ther. 2017;10(4):245–251.
  • Reville PK, Kadia TM. Maintenance therapy in AML. Front. Oncol. 2021;10:1–10.
  • Salas M, Henderson M, Wientzek-Fleischmann A, et al. Validated instruments of quality of life (QOL) in patients with acute myeloid leukemia (AML) and other cancers. Front. Pharmacol. 2020;11:1109.
  • Stauder R, Lambert J, Desruol-Allardin S, et al. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: literature review and landscape analysis. Eur J Haematol. 2020;104(5):476–487.
  • Kayastha N, Wolf SP, Locke SC, et al. The impact of remission status on patients’ experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data. Support Care Cancer. 2018;26(5):1437–1445.
  • Boucher NA, Johnson KS, LeBlanc TW. Acute leukemia patients’ needs: qualitative findings and opportunities for early palliative care. J Pain Symptom Manage. 2018;55(2):433–439.
  • Brédart A, Marrel A, Abetz-Webb L, et al. Interviewing to develop Patient-Reported outcome (PRO) measures for clinical research: eliciting patients’ experience. Health Qual Life Outcomes. 2014;12:15.
  • Cella D, Jensen SE, Webster K, et al. Measuring health-related quality of life in leukemia: the functional assessment of cancer therapy - Leukemia (FACT-Leu) questionnaire. Value Health. 2012;15(8):1051–1058.
  • He J, Pierson R, Loefgren C, et al. Patient-Reported outcomes validation of the FACT-Leu in acute myeloid leukemia: a review of baseline characteristics in AML2002. Blood. 2018;132(Supplement 1):3590.
  • Peipert JD, Efficace F, Pierson R, et al. Patient-reported outcomes predict overall survival in older patients with acute myeloid leukemia. J Geriatr Oncol. 2022;13(7):935–939.
  • LeBlanc TW, Russell NH, Hernandez-Aldama L, et al. Patient, family member and physician perspectives and experiences with AML treatment Decision-Making. Oncol Ther. 2022;10(2):421–440.
  • LeBlanc TW, Fish LJ, Bloom CT, et al. Patient experiences of acute myeloid leukemia: a qualitative study about diagnosis, illness understanding, and treatment decision-making. Psychooncology. 2017;26(12):2063–2068.
  • Buckley SA, Jimenez-Sahagun D, Othus M, et al. Quality of life from the perspective of the patient with acute myeloid leukemia. Cancer. 2018;124(1):145–152.
  • Tomaszewski EL, Fickley CE, Maddux L, et al. The patient perspective on living with acute myeloid leukemia. Oncol Ther. 2016;4(2):225–238.
  • Shah M, Crooks P, New M. Psy218 - symptom and impact disturbance: findings from a qualitative assessment of patients with acute myeloid leukemia (aml). Value Health. 2018;21(Supplement 3):S473–S474.
  • Kennedy VE, Smith CC. FLT3 mutations in acute myeloid leukemia: key concepts and emerging controversies. Front Oncol. 2020;10:612880.
  • Testa U, Pelosi E. The impact of FLT3 mutations on the development of acute myeloid leukemias. Leuk Res Treatment. 2013;2013:275760.
  • Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity - Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1 - Eliciting concepts for a new PRO instru. Value Health. 2011;14(8):967–977.
  • Filipovich AH, Weisdorf D, Pavletic S, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–956.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.